Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ PUMA alpha Recombinant Rabbit Monoclonal Antibody (9C5W5)
Rabbit Recombinant Monoclonal Antibody
Supplier: Invitrogen™ MA535398
Description
Immunogen sequence: AEQHLESPVP SAPGALAGGP TQAAPGVRGE EEQWAREIGA QLRRMADDLN AQYERRRQEE QQRHRPSPWR VLYNLIMGLL PLPRGHRAPE MEPN.
PUMA is one of the pro-apoptotic Bcl-2 family members including Bax and Noxa, which are also transcriptional targets of p53. The PUMA gene encodes two BH3 domain-containing proteins termed PUMA-a and PUMA-b. PUMA proteins bind Bcl-2, localize to the mitochondria, and induce cytochrome c release and apoptosis in response to p53. PUMA may be a direct mediator of p53-induced apoptosis. Antisense inhibition of PUMA expression reduced the apoptotic response to p53, and PUMA is likely to play a role in mediating p53-induced cell death through the cytochrome c/Apaf-1-dependent pathway.
Specifications
PUMA alpha | |
Recombinant Monoclonal | |
0.57 mg/mL | |
PBS with 0.05% BSA, 50% glycerol and 0.02% sodium azide; pH 7.3 | |
Q80ZG6, Q99ML1, Q9BXH1 | |
BBC3 | |
A synthetic peptide corresponding to a sequence within amino acids 100-193 of human PUMA (NP_055232.1). | |
100 μL | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
ELISA, Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
9C5W5 | |
Unconjugated | |
BBC3 | |
BBC3; BCL2 binding component 3; Bcl-2 binding component 3; bcl-2-binding component 3; Bcl-2-binding component 3, isoforms 1/2; Bcl-2-binding component 3, isoforms 3/4; BH3-only; FLJ42994; JFY1; JFY-1; p53 up-regulated modulator of apoptosis; PUMA; PUMA/JFY1 | |
Rabbit | |
Affinity Chromatography | |
RUO | |
170770, 27113, 317673 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction